These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8620669)

  • 41. The effect of zileuton on antipyrine and indocyanine green disposition.
    St Peter JV; Braeckman RA; Granneman GR; Locke CS; Cavanaugh JH; Awni WM
    Clin Pharmacol Ther; 1995 Mar; 57(3):299-308. PubMed ID: 7697947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma protein binding and interaction studies with piroxicam.
    Trnavská Z; Trnavský K
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):81-5. PubMed ID: 6493354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of naproxen on the kinetics of elimination and anticoagulant activity of a single dose or warfarin.
    Slattery JT; Levy G; Jain A; McMahon FG
    Clin Pharmacol Ther; 1979 Jan; 25(1):51-60. PubMed ID: 758243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protein binding of indomethacin: binding of indomethacin to human plasma albumin and its displacement from binding by ibuprofen, phenylbutazone and salicylate, in vitro.
    Mason RW; McQueen EG
    Pharmacology; 1974; 12(1):12-9. PubMed ID: 4419599
    [No Abstract]   [Full Text] [Related]  

  • 45. Stereoselective binding of isradipine to human plasma proteins.
    Oravcová J; Sojková D; Bencsíková E; Bohov P; Trnovec T
    Chirality; 1995; 7(3):167-72. PubMed ID: 7794694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease.
    Berger W; De Chandt MT; Cairns CB
    Int J Clin Pract; 2007 Apr; 61(4):663-76. PubMed ID: 17394438
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Zileuton.
    McGill KA; Busse WW
    Lancet; 1996 Aug; 348(9026):519-24. PubMed ID: 8757156
    [No Abstract]   [Full Text] [Related]  

  • 48. Kinetics and mechanism of degradation of Zileuton, a potent 5-lipoxygenase inhibitor.
    Alvarez FJ; Slade RT
    Pharm Res; 1992 Nov; 9(11):1465-73. PubMed ID: 1475235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enantiomeric analysis of terfenadine in rat plasma by HPLC.
    Zamani K; Conner DP; Weems HB; Yang SK; Cantilena LR
    Chirality; 1991; 3(6):467-70. PubMed ID: 1812957
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of 5-lipoxygenase inhibitor zileuton on airway responses to inhaled swine house dust in healthy subjects.
    Larsson BM; Kumlin M; Sundblad BM; Larsson K; Dahlén SE; Palmberg L
    Respir Med; 2006 Feb; 100(2):226-37. PubMed ID: 15939582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of the human liver cytochrome P450 enzymes involved in the in vitro metabolism of a novel 5-lipoxygenase inhibitor.
    Machinist JM; Mayer MD; Roberts EM; Surber BW; Rodrigues AD
    Drug Metab Dispos; 1998 Oct; 26(10):970-6. PubMed ID: 9763401
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A simplified high-performance liquid chromatographic method for direct determination of warfarin enantiomers and their protein binding in stroke patients.
    Cai WM; Hatton J; Pettigrew LC; Dempsey RJ; Chandler MH
    Ther Drug Monit; 1994 Oct; 16(5):509-12. PubMed ID: 7846751
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of naproxen on the steady-state serum concentration and anticoagulant activity of warfarin.
    Jain A; McMahon FG; Slattery JT; Levy G
    Clin Pharmacol Ther; 1979 Jan; 25(1):61-6. PubMed ID: 758244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Zileuton reduces inflammatory reaction and brain damage following permanent cerebral ischemia in rats.
    Tu XK; Yang WZ; Wang CH; Shi SS; Zhang YL; Chen CM; Yang YK; Jin CD; Wen S
    Inflammation; 2010 Oct; 33(5):344-52. PubMed ID: 20204486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The displacement of L-tryptophan and dipeptides from bovine albumin in vitro and from human plasma in vivo by antirheumatic drugs.
    McArthur JN; Dawkins PD; Smith MJ
    J Pharm Pharmacol; 1971 Jun; 23(6):393-8. PubMed ID: 4397176
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparative pharmacokinetics of coumarin anticoagulants XXV: Warfarin-ibuprofen interaction in rats.
    Slattery JT; Yacobi A; Levy G
    J Pharm Sci; 1977 Jul; 66(7):943-7. PubMed ID: 886455
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Zileuton, a 5-lipoxygenase inhibitor, increases production of thromboxane A2 and platelet aggregation in patients with asthma.
    Wu X; Dev A; Leong AB
    Am J Hematol; 2003 Sep; 74(1):23-5. PubMed ID: 12949886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group.
    Israel E; Cohn J; Dubé L; Drazen JM
    JAMA; 1996 Mar; 275(12):931-6. PubMed ID: 8598621
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enantioselective structure-pharmacokinetic relationships of ring substituted warfarin analogues in the rat.
    Baars LG; Schepers MT; Hermans JJ; Dahlmans HJ; Thijssen HH
    J Pharm Pharmacol; 1990 Dec; 42(12):861-6. PubMed ID: 1983149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The protein binding of timegadine determined by equilibrium dialysis.
    George S; McBurney A; Ward J
    Br J Clin Pharmacol; 1984 Nov; 18(5):785-90. PubMed ID: 6508987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.